| Structure |
Chemical Name |
CAS |
MF |
 |
Avermectin A1a, 25-cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-23-hydroxy-5-(hydroxyimino)-, (23S)- (9CI) |
165108-08-7 |
C43H63NO12 |
 |
Cytarabine Impurity 10 |
84902-98-7 |
C4H6N2O3 |
 |
Ribavirin IMp. F (EP) |
|
|
 |
Fondaparinux sodium impurity 8 |
2088176-32-1 |
C30H50N2O46S7 |
 |
S-(+)-O-DesMethyl-Venlafaxine-d6 |
1062609-99-7 |
C16H25NO2 |
 |
Rivaroxaban Impurity 35 |
2206360-74-7 |
C23H24N4O6 |
 |
1-Hydroxy-7-Methoxy-1,2,3,4-tetrahydronaphthalene |
32820-10-3 |
C11H14O2 |
 |
Sugammadex sodium Decomposition process Impurity 3 |
|
|
 |
4'-Hydroxy TorseMide |
99300-67-1 |
C16H20N4O4S |
 |
MiraBegron Impurity F |
|
|
![5-(2-クロロベンジル)-チエノ[3,2-C]ピリジニウムクロリド](/CAS/GIF/53885-64-6.gif) |
5-(2-クロロベンジル)-チエノ[3,2-C]ピリジニウムクロリド |
53885-64-6 |
C14H11Cl2NS |
 |
Lercanidipine Impurity 6 |
786625-22-7 |
C37H43N3O6 |
 |
Arbidol Impurity 27 |
|
|
 |
Ezetimibe Impurity 28 |
|
|
 |
1,2-Ethanediamine, N,N,N',N'-tetrakis(2-aminoethyl)- |
4097-90-9 |
C10H28N6 |
 |
Cefoxitin EP Impurity G |
|
|
 |
QBWNUEJPRUVNTD-FOIQADDNSA-N |
1346602-17-2 |
C22H17N3O5 |
![3-(1,4-Dihydro-5-Methyl-4-oxo-7-propyliMidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzenesulfonic Acid](/CAS/20200611/GIF/437717-43-6.gif) |
3-(1,4-Dihydro-5-Methyl-4-oxo-7-propyliMidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzenesulfonic Acid |
437717-43-6 |
C17H20N4O5S |
 |
1-(3-Cyanopyridyl-2)-2-Phenyl-4-Methylpyperazine |
61337-88-0 |
C17H18N4 |
 |
Vonoprazan Impurity 1 |
881732-90-7 |
C17H17N3O2S |
 |
Sitagliptin Defuoro IMpurity 5 |
486460-31-5 |
C16H16F5N5O |
 |
Lidocaine Impurity |
70336-49-1 |
C20H22N2O2 |
 |
Agomelatine Impurity 11 |
|
|
![(S)-1-[(4-クロロフェニル)フェニルメチル]ピペラジン](/CAS/GIF/439858-21-6.gif) |
(S)-1-[(4-クロロフェニル)フェニルメチル]ピペラジン |
439858-21-6 |
C17H19ClN2 |
 |
(R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid |
112106-16-8 |
C11H20O4 |
 |
Dasatinib IMpurity 3 |
|
|
 |
Pyridine, 2-(diethylboryl)- (9CI) |
385804-67-1 |
C9H14BN |
 |
Oseltamivir Impurity 67 |
|
|
 |
Oseltamivir Impurity 69 |
|
|
 |
Parecoxib Impurity J |
|
|
 |
Prasugrel Acetyl IMpurity |
1443034-67-0 |
C18H18FNO3S |
 |
EsMolol Acid SodiuM Salt |
83356-60-9 |
C15H22NNaO4 |
 |
Ibrutinib Impurity 6 |
1917333-91-5 |
C28H26N6O3 |
 |
Aripiprazole Related CoMpound B |
1424858-02-5 |
C26H32N2O5 |
 |
Medetomidine Impurity 14 |
79924-14-4 |
C13H16N2 |
 |
Apixaban Impurity 89 |
|
|
![L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]-](/CAS/20200401/GIF/290298-02-1.gif) |
L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]- |
290298-02-1 |
C16H24N2O3 |
 |
ジ-ノルブデソニド(MIXTURE OF DIASTEREOMERS) |
1040085-98-0 |
C23H30O6 |
 |
(R)-4-fluoro-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C23H24FN7O4 |
 |
Cinacalcet Impurity 23 |
|
|
 |
1-フェニル-5-(ピリジン-2-イル)-1,2-ジヒドロピリジン-2-オン |
381725-50-4 |
C16H12N2O |
 |
2-フェノキシ-4-ニトロフェノール |
70995-08-3 |
C12H9NO4 |
 |
AFuroseMide IMp. A (EP) |
|
|
 |
(1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)cyclopropanecarboxylic acid |
1369769-35-6 |
C17H17FN2O3 |
![(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid](/CAS2/GIF/254452-86-3.gif) |
(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
254452-86-3 |
C25H24FNO4 |
 |
PraMipexole IMpurity Z1/Z2 |
|
|
 |
Benzeneacetic acid, 3-(2-amino-1,1-dimethyl-2-oxoethyl)-α,α-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)- |
2469244-33-3 |
C17H22N4O3 |
![1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride](/CAS/20200401/GIF/2252446-70-9.gif) |
1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
|
2252446-70-9 |
C22H27ClFN3O4 |
![1-[2-[[(2R)-テトラヒドロ-4β-ヒドロキシ-6-オキソ-2H-ピラン]-2α-イル]エチル]-5-(4-フルオロフェニル)-2-イソプロピル-4,N-ジフェニル-1H-ピロール-3-カルボアミド](/CAS/GIF/125995-03-1.gif) |
1-[2-[[(2R)-テトラヒドロ-4β-ヒドロキシ-6-オキソ-2H-ピラン]-2α-イル]エチル]-5-(4-フルオロフェニル)-2-イソプロピル-4,N-ジフェニル-1H-ピロール-3-カルボアミド |
125995-03-1 |
C33H33FN2O4 |
 |
Methoxyvinpocetine |
|
|
 |
AzithroMycin IMpurity K |
|
|
 |
Rosuvastatin Impurity 146 |
|
|
 |
Ibuprofen Impurity 2 |
|
C13H18O2 |
 |
AtracuriuM IMpurity H (Mixture of cis, trans(H1), cis, cis(H2)
tans, trans IsoMer) |
1248429-33-5 |
|
![4-[2-ヒドロキシ-3-[(1-メチルエチル)アミノ]プロポキシ]ベンゼンプロパン酸](/CAS/GIF/81148-15-4.gif) |
4-[2-ヒドロキシ-3-[(1-メチルエチル)アミノ]プロポキシ]ベンゼンプロパン酸 |
81148-15-4 |
C15H23NO4 |
 |
4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
160552-54-5 |
C8H11N3O4S |
 |
1,2-Benzenedicarboxylic acid, 3-amino-, 2-ethyl ester |
1822756-03-5 |
C10H11NO4 |
 |
Moxifloxacin Impurities |
|
|
 |
N-メタンスルホニル-N-(4-ニトロ-2-フェノキシフェニル)メタンスルホンアミド |
51765-72-1 |
C14H14N2O7S2 |
 |
Paroxetine EP Impurity J HCl |
|
|
![N-[(1S)-2-アミノ-2-オキソ-1-(フェニルメチル)エチル]-2-ピラジンカルボキサミド](/CAS/GIF/289472-80-6.gif) |
N-[(1S)-2-アミノ-2-オキソ-1-(フェニルメチル)エチル]-2-ピラジンカルボキサミド |
289472-80-6 |
C14H14N4O2 |
 |
5-(3,5-ジメトキシ-4-エトキシベンジル)-2,4-ピリミジンジアミン |
78025-68-0 |
C15H20N4O3 |
 |
itraconazole impurity f |
|
|
 |
BDJS-SH 2 |
36585-31-6 |
C12H18N2O2 |
 |
Ticagrelor Impurity 98 |
|
|
 |
Roxatidine Impurity 10 |
|
|
 |
Montelukast Sodium EP Impurity G |
1428448-96-7 |
C35H37ClNNaO3S |
 |
Olodaterol Impurity 30 |
|
|
 |
Oseltamivir EP Impurity A |
1391047-93-0 |
C14H24N2O4 |
 |
(2R,3R,4R,5R)-5-(4-benzaMido-2-oxopyriMidin-1(2H)-yl)-2-((benzoyloxy)Methyl)-4-chloro-4-Methyltetrahydrofuran-3-yl benzoate |
1496551-70-2 |
C31H26ClN3O7 |
 |
Apixaban Impurity 52 |
1620494-31-6 |
C31H29N5O4 |
![IMp. A (EP): 8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one](/) |
IMp. A (EP): 8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one |
|
|
![1-[3,5-ビス(フェニルメトキシ)フェニル]-2-ブロモエタノン](/CAS/GIF/28924-18-7.gif) |
1-[3,5-ビス(フェニルメトキシ)フェニル]-2-ブロモエタノン |
28924-18-7 |
C22H19BrO3 |
 |
4,6-DIAMINOINDAZOLE |
885518-52-5 |
C7H8N4 |
 |
Desethyl Acetate (E)-CefuroxiMe Axetil |
97232-97-8 |
C16H16N4O8S |
 |
For the determination of
impurities in lsobutylene |
|
|
 |
Mouse Neonatal Thyroxine,NN-T4 ELISA Kit |
|
|
 |
4-(3-AMino-phenyl)-Morpholin-3-one |
1082495-22-4 |
C10H12N2O2 |
 |
Sitafloxacin Impurity 5 |
1630983-99-1 |
C15H12ClF4NO3 |
 |
AMoxicillin iMpurity L |
|
C16H19N3O5S |
 |
Lercanidipine iMpurity |
320750-19-4 |
C37H43N3O6 |
 |
Milrinone Impurity 5 |
|
|
 |
Istradefylline Impurity A |
|
|
![3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-1,6-dihydro-6-oxo-, hydrochloride (1:)](/CAS/20211123/GIF/570403-05-3.gif) |
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-1,6-dihydro-6-oxo-, hydrochloride (1:) |
570403-05-3 |
C23H26Cl3N5O2S2 |
 |
CefazolinH020-02-I-02 |
|
|
 |
SofosBuvir impurity 21 |
1496552-50-1 |
C22H29ClN3O9P |
 |
LCZ696(valsartan + sacubitril) impurity 33 |
|
|
 |
BIRG 616 BS |
287980-84-1 |
C12H10N4O |
 |
N-acetyl-N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetaMide |
1379005-34-1 |
C17H19NO3 |
 |
Posaconazole iMpurity 5 |
|
|
 |
Alvatrombopag Impurity 84 |
|
|
 |
ibrutinib iMpurity B |
|
|
 |
Sitafloxacin Impurity ZZ-A-01 |
|
|
 |
Bortezomib Impurity P |
|
|
 |
Loratadine Impurity 2 |
|
C22H23ClN2O2 |
 |
Ribavirin IMpurity E |
58151-90-9 |
C15H16N4O6 |
![propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]-](/CAS/GIF/144702-27-2.gif) |
propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]- |
144702-27-2 |
C33H29N5 |
 |
Canagliflozin Impurity G |
|
|
 |
Posaconazole impurity 18 |
1819334-66-1 |
C44H49F2N8O4+ |
 |
Ticagrelor Impurity 40 |
|
|